News
CNVVF
2.630
NaN%
--
Jefferies Sticks to Its Buy Rating for ConvaTec (CTEC)
TipRanks · 1d ago
Barclays Reaffirms Their Buy Rating on ConvaTec (CTEC)
TipRanks · 05/08 05:46
Berenberg Bank Sticks to Their Buy Rating for ConvaTec (CTEC)
TipRanks · 04/21 16:59
Convatec Director Departs After Driving Innovation-Led Turnaround
TipRanks · 04/13 11:02
ConvaTec (CTEC) Gets a Buy from Jefferies
TipRanks · 04/10 12:55
ConvaTec (CTEC) Receives a Buy from Barclays
TipRanks · 04/10 06:41
ConvaTec: Upgraded Medium-Term Outlook and ‘Accelerate’ Strategy Support Buy Rating
TipRanks · 04/09 11:05
Convatec launches ‘Accelerate’ strategy with upgraded growth and margin targets
TipRanks · 04/09 06:17
Deutsche Bank Sticks to Their Buy Rating for ConvaTec (CTEC)
TipRanks · 04/08 14:45
Goldman Sachs Keeps Their Buy Rating on ConvaTec (CTEC)
TipRanks · 04/07 16:38
RBC Capital Sticks to Their Buy Rating for ConvaTec (CTEC)
TipRanks · 04/01 16:25
Convatec Sets Date and Details for 2026 Annual General Meeting
TipRanks · 03/17 13:04
Convatec Executives Receive Vested Share Awards Under Long-Term Incentive Plans
TipRanks · 03/17 11:02
Convatec Introduces Co-Branded eakin freeseal® Ostomy Seal in North America, Expanding the ESENTA™ Family of Accessories
Barchart · 03/16 09:03
Convatec Grants New Long‑Term Equity Awards to CEO and CFO
TipRanks · 03/12 14:32
Stifel Nicolaus Remains a Buy on ConvaTec (CTEC)
TipRanks · 03/11 17:05
Convatec Publishes 2025 Annual Report and Files With UK Regulator
TipRanks · 03/10 13:02
Goldman Sachs Reaffirms Their Buy Rating on ConvaTec (CTEC)
TipRanks · 03/10 10:26
Citi Reaffirms Their Buy Rating on ConvaTec (CTEC)
TipRanks · 03/05 17:09
ConvaTec (CTEC) Gets a Buy from RBC Capital
TipRanks · 03/05 07:49
More
Webull provides a variety of real-time CNVVF stock news. You can receive the latest news about Convatec Group Plc through multiple platforms. This information may help you make smarter investment decisions.
About CNVVF
Convatec Group Plc is a United Kingdom-based medical products and technologies company. The Company is engaged in the development, manufacture and sale of medical products, services, and technologies. It is focused on solutions for the management of chronic conditions. It markets and sells its solutions and services in four categories, such as Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. Advanced Wound Care includes advanced dressings for the management of acute and chronic wounds resulting from ongoing conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. Ostomy Care includes devices, accessories, and personalized services for individuals with a stoma. Continence Care includes products and services for people with urinary continence issues related to spinal cord injuries and other causes. Infusion Care includes disposable infusion sets used in insulin pump therapy for people with diabetes.